Copyright
©The Author(s) 2024.
World J Hepatol. Apr 27, 2024; 16(4): 566-600
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.566
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.566
NPs | Size | Tested model | Dose & route of administration | Effects & mechanism | Ref. |
Nano-Clay | 57.8 ± 12.3 nm & 648.3 ± 232.2 nm | BALB/C mice | 1, 5, 10, 20 mg/kg b.w. (Iv) 24 h; Co-administered with Ccl4, paraquat, cisplatin | ALT, AST (increased) | [163] |
NCD (modified nanocellulose with oxalate esters) | 100 nm (SEM) | Wistar rat | 50 & 100 mg/kg b.w. (oral) for 7 d | ALT, AST (increased); CAT, GPx activity (decreased); MPO activity (increased); iNOS, Bax (increased); dialated sinusoidal space, vacuolated hepatocytes, cellular infiltration | [29] |
Oxidative stress | |||||
Polystyrene | PS NPs 158.8 ± 1.3 nm; aPS NPs 117.0 ± 1.8 nm (SEM) | ICR mice | 50 mg/kg/d (oral) for 7 d | Glucose, HDL-C, TG, TC (increased in blood); LDL-C (decreased in blood); Activation of PI3K/AKT/GLUT4 & SREBP-1/PPARγ/ATGL signaling pathways; TG decomposition; Lipid accumulation (increased); Nuclear pyknosis, blurred intercellular space, central hepatic vein congestion, hepatic ballooning; Compared to PS NPs, aPS NPs showed higher toxicity | [28] |
Disruption of glycolipid metabolism | |||||
Chitosan (CsNPs) | 18 ± 1 nm (DLS) | BHAL cell | ≥ 0.5% w/v for 4 h | Readily internalized; Disrupt membrane integrity; ALT leakage; CYP3A4 enzyme activity (increased); necrotic or autophagic cell death | [27] |
- Citation: Das SK, Sen K, Ghosh B, Ghosh N, Sinha K, Sil PC. Molecular mechanism of nanomaterials induced liver injury: A review. World J Hepatol 2024; 16(4): 566-600
- URL: https://www.wjgnet.com/1948-5182/full/v16/i4/566.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i4.566